Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

MedXCell S.A.

MedXCell SA is a Swiss specialist healthcare group of entities with clinical-stage projects whose mission is to harness the power of cellular therapies to make lives better. It is dedicated to developing and manufacturing innovative off-the-shelf cellular therapies offering state-of-the-art, cost-effective and safe solutions for a wide range of patient needs. The company enjoys a close relationship with academic research, most notably with the Institute for Regenerative Medicine and Biotherapy from the French University Hospital of Montpellier (CHU Montpellier), France. The MedXCell Group has a workforce currently numbering 25 employees. *

 

Period Start 2021-06-04 existent
  Group MedXCell (Group)
Product Industry cell therapy
Persons Person Zbinden, Laurent (MedXCell 202203 CEO)
  Person 2 Brodard, Lionel (MedXCell 202106 CFO)
     
Region Region Montreux
  Country Switzerland
  Street 20C Avenue des Planches
  City 1820 Montreux
    Address record changed: 2022-04-04
     
Basic data Employees n. a.
     
    * Document for »About Section«: MedXCell S.A.. (6/4/21). "Press Release: MedXCell SA Has Successfully Closed a CHF 5.3 Million Series A". Montreux.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for MedXCell (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top